Author
Listed:
- Yixun Su
(Seventh Affiliated Hospital of Sun Yat-sen University
Third Military Medical University)
- Hui Li
(Seventh Affiliated Hospital of Sun Yat-sen University
Third Military Medical University)
- Wenjie Zhang
(Hefei University of Technology)
- Shi Tao
(Hefei University of Technology)
- Qi Wang
(Seventh Affiliated Hospital of Sun Yat-sen University
Third Military Medical University)
- Xuan Zhang
(Hefei University of Technology)
- Mi Zhou
(Chongqing University)
- Xiaomin Huang
(Seventh Affiliated Hospital of Sun Yat-sen University)
- Chenmeng Wang
(Seventh Affiliated Hospital of Sun Yat-sen University
Third Military Medical University)
- Yong Tang
(Chengdu University of Traditional Chinese Medicine)
- Hui Chen
(University of Technology Sydney)
- Alexei Verkhratsky
(The University of Manchester
University of the Basque Country
IKERBASQUE Basque Foundation for Science
Guangdong Provincial Key Laboratory of Digestive Cancer Research)
- Zhengbao Zha
(Hefei University of Technology)
- Jianqin Niu
(Third Military Medical University
Chongqing Key Laboratory of Neurobiology)
- Chenju Yi
(Seventh Affiliated Hospital of Sun Yat-sen University
Guangdong Provincial Key Laboratory of Digestive Cancer Research
Guangdong Provincial Key Laboratory of Brain Function and Disease
Shenzhen Key Laboratory of Chinese Medicine Active Substance Screening and Translational Research)
Abstract
Alzheimer’s disease (AD), the leading cause of senile dementia, lacks effective therapies. While microglia are central to AD pathology, key therapeutic targets remain unclear. Here we identify microglial connexin43 (Cx43) hemichannels as a regulator of microglial reactivity in AD, positioning them as a promising therapeutic target. Post-mortem AD patient tissue showed elevated Cx43 levels in periplaque microglia. In the APPswe/PS1dE9 (APP/PS1) mouse model of amyloidosis, we demonstrated that microglial Cx43 hemichannels correlated with microglial malfunction, which in turn exacerbated β-amyloid pathology. Ablation of microglial Cx43 hemichannels by genetic knockout shifts microglia to a neuroprotective phenotype, enhancing the microglia-plaque interaction while suppressing neurotoxicity, thereby mitigating the progression of AD-like pathology. We developed TAT-Cx43@LNPs, a Cx43 hemichannel-targeting peptide delivered by a lipid nanoparticle system, which effectively delayed and rescued β-amyloid-related neuropathology and cognitive impairment in APP/PS1 mice. This study provides evidence for advancing Cx43 hemichannel targeting therapy into clinical trials.
Suggested Citation
Yixun Su & Hui Li & Wenjie Zhang & Shi Tao & Qi Wang & Xuan Zhang & Mi Zhou & Xiaomin Huang & Chenmeng Wang & Yong Tang & Hui Chen & Alexei Verkhratsky & Zhengbao Zha & Jianqin Niu & Chenju Yi, 2025.
"Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis,"
Nature Communications, Nature, vol. 16(1), pages 1-20, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60746-w
DOI: 10.1038/s41467-025-60746-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60746-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.